nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway
|
Nilsson, Mona |
|
|
22 |
6 |
p. |
artikel |
2 |
Age Does Not Impact Cancer Specific Mortality: From Sub-Distributional and Cause-Specific Hazard Analysis in RCC Patients Undergoing Radical Nephrectomy and Thrombectomy
|
Kim, Younjuong |
|
|
22 |
6 |
p. |
artikel |
3 |
Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma
|
Xu, Vincent E. |
|
|
22 |
6 |
p. |
artikel |
4 |
Appearance of New Lesions Associate With Poor Prognosis in Pembrolizumab-Treated Urothelial Carcinoma
|
Hara, Takuto |
|
|
22 |
6 |
p. |
artikel |
5 |
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder
|
Liveringhouse, Casey |
|
|
22 |
6 |
p. |
artikel |
6 |
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
|
Bakaloudi, Dimitra Rafailia |
|
|
22 |
6 |
p. |
artikel |
7 |
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
|
Grivas, Petros |
|
|
22 |
6 |
p. |
artikel |
8 |
Can Patients With Urogenital Cancer Rely on Artificial Intelligence Chatbots for Treatment Decisions?
|
Erkan, Anil |
|
|
22 |
6 |
p. |
artikel |
9 |
Characteristics of Abdominal Fat Based on CT Measurements to Predict Early Recurrence After Initial Surgery of NMIBC in Stage Ta/T1
|
Yu, Nengfeng |
|
|
22 |
6 |
p. |
artikel |
10 |
Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer
|
McKenzie, Jane |
|
|
22 |
6 |
p. |
artikel |
11 |
Clinical, Prognosis, and Treatment Effect Features Analysis of Metachronous and Synchronous UTUC and BUC
|
Zuo, Wei |
|
|
22 |
6 |
p. |
artikel |
12 |
Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching
|
Kobayashi, Keita |
|
|
22 |
6 |
p. |
artikel |
13 |
Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom and France
|
Wong, Bryan |
|
|
22 |
6 |
p. |
artikel |
14 |
Concordance Between the Expert Reading of Biparametric-MRI and the Nonexpert Multiparametric-MRI for the Detection of Clinically Significant Prostate Cancer: Clinical Implications
|
Paesano, Nahuel |
|
|
22 |
6 |
p. |
artikel |
15 |
Detection of Apical Cancer with Novel Imaging Modalities to Predict Apical Margin Positivity in Robotic Assisted Radical Prostatectomy
|
Wagaskar, Vinayak G. |
|
|
22 |
6 |
p. |
artikel |
16 |
Development and Validation of a Nomogram for Predicting Postoperative Recurrence-Free Survival in Patients With Nonmetastatic Pathological T3a Stage Renal Cell Carcinoma
|
Li, Xintao |
|
|
22 |
6 |
p. |
artikel |
17 |
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study
|
Reike, Moritz J. |
|
|
22 |
6 |
p. |
artikel |
18 |
Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS—Meet-URO 26 Real-World Study
|
Patrikidou, Anna |
|
|
22 |
6 |
p. |
artikel |
19 |
Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors
|
Xiang, Jenny J |
|
|
22 |
6 |
p. |
artikel |
20 |
Efficacy and Safety of Combination AKT and Androgen Receptor Signaling Inhibition in Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis
|
Nahar, Tulika A.K. |
|
|
22 |
6 |
p. |
artikel |
21 |
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
|
Guida, Annalisa |
|
|
22 |
6 |
p. |
artikel |
22 |
Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis
|
Maddah, Mohammad Moein |
|
|
22 |
6 |
p. |
artikel |
23 |
Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients
|
Liu, Ming-Zhu |
|
|
22 |
6 |
p. |
artikel |
24 |
Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients
|
Freedland, Stephen J. |
|
|
22 |
6 |
p. |
artikel |
25 |
High Sensitivity Circulating Tumor-DNA Assays in Renal Cell Carcinoma–Are we there yet?
|
Sidhom, Fady |
|
|
22 |
6 |
p. |
artikel |
26 |
Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer
|
Qian, Zhiyu |
|
|
22 |
6 |
p. |
artikel |
27 |
Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer
|
Tural, Deniz |
|
|
22 |
6 |
p. |
artikel |
28 |
Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial
|
Chappidi, Meera R. |
|
|
22 |
6 |
p. |
artikel |
29 |
Impact of Urethra-Preserving Surgery During Radical Cystectomy: An Optimal Urethral Management in the Robotic Era
|
Zennami, Kenji |
|
|
22 |
6 |
p. |
artikel |
30 |
Landscape of Genomic Profiling and Circulating Tumor DNA Among Rare Genitourinary Cancers
|
Kazarian, Austin G |
|
|
22 |
6 |
p. |
artikel |
31 |
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection
|
Baky, Fady |
|
|
22 |
6 |
p. |
artikel |
32 |
Markers in Identifying Pathological Complete Response Status in Muscle Invasive Bladder Cancer Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy
|
Piao, Chengri |
|
|
22 |
6 |
p. |
artikel |
33 |
Metastatic Prostate Cancer: Sequential or Combination Therapy?
|
Dottorini, Lorenzo |
|
|
22 |
6 |
p. |
artikel |
34 |
National Trends in PSA Cancer Screening With Parallel Investigation of Colorectal Cancer Screening: An Analysis of the CDC Behavioral Risk Factor Surveillance System From 2012 to 2022
|
Nguyen, Anh |
|
|
22 |
6 |
p. |
artikel |
35 |
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma
|
Saitta, Cesare |
|
|
22 |
6 |
p. |
artikel |
36 |
Nomograms to Appraise The Risk of Chronic Kidney Disease After Radical Cystectomy: Shifting The Focus to Prevention
|
Artiles Medina, Alberto |
|
|
22 |
6 |
p. |
artikel |
37 |
Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database
|
Moldovan, Matthew |
|
|
22 |
6 |
p. |
artikel |
38 |
Outcomes of Radical Radiotherapy for the Treatment of Localized Renal Pelvic and Ureteral Carcinoma Intolerant to Surgery: A Real-World Study
|
Liu, Ming-Zhu |
|
|
22 |
6 |
p. |
artikel |
39 |
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma
|
Nicaise, Edouard H. |
|
|
22 |
6 |
p. |
artikel |
40 |
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
|
Ornstein, Moshe C. |
|
|
22 |
6 |
p. |
artikel |
41 |
Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer
|
Obasi, Jennifer |
|
|
22 |
6 |
p. |
artikel |
42 |
Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
|
Kardoust Parizi, Mehdi |
|
|
22 |
6 |
p. |
artikel |
43 |
Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE Study
|
Stecca, Carlos |
|
|
22 |
6 |
p. |
artikel |
44 |
Prognostic Nomogram, Demographics and Comparative Analysis of Urinary Bladder Small Cell and Large Cell Neuroendocrine Carcinoma
|
Ullah, Asad |
|
|
22 |
6 |
p. |
artikel |
45 |
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance
|
Perera, Marlon |
|
|
22 |
6 |
p. |
artikel |
46 |
Quantitative Investigation of MicroRNA-32 in the Urine of Prostate Cancer Patients and Its Relationship With Clinicopathological Characteristics
|
Mahdizade, Amir Hossein |
|
|
22 |
6 |
p. |
artikel |
47 |
Rare type of Bellini Duct Carcinoma in a Patient With Cacchi–Ricci Disease: A Case Report and Mini-Review
|
Franco, Antonio |
|
|
22 |
6 |
p. |
artikel |
48 |
Real-life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel – A multicentric Study From Portugal
|
Botelho, Francisco |
|
|
22 |
6 |
p. |
artikel |
49 |
Real-world Efficacy and Safety of Low-Dose Abiraterone With Food and Standard-Dose Abiraterone in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Analysis
|
Do, Tu Anh |
|
|
22 |
6 |
p. |
artikel |
50 |
Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study
|
Liontos, M. |
|
|
22 |
6 |
p. |
artikel |
51 |
RETRACTED: Roles of Long Noncoding RNA in Prostate Cancer Pathogenesis
|
Zhao, Tongyue |
|
|
22 |
6 |
p. |
artikel |
52 |
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
|
Scilipoti, Pietro |
|
|
22 |
6 |
p. |
artikel |
53 |
Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database
|
Zerdan, Maroun Bou |
|
|
22 |
6 |
p. |
artikel |
54 |
Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma
|
Seyedin, S.N. |
|
|
22 |
6 |
p. |
artikel |
55 |
Salvage Stereotactic Radiotherapy for Nodal Oligo-Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Aman, Ayesha |
|
|
22 |
6 |
p. |
artikel |
56 |
Serum Androgens as Predictive Biomarkers: Results From a Randomized Clinical Trial Comparing Enzalutamide and Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer
|
Ternov, Klara K. |
|
|
22 |
6 |
p. |
artikel |
57 |
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
|
Bakaloudi, Dimitra Rafailia |
|
|
22 |
6 |
p. |
artikel |
58 |
Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis
|
O'Dwyer, Richard |
|
|
22 |
6 |
p. |
artikel |
59 |
Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial Carcinoma
|
Zappia, Jason |
|
|
22 |
6 |
p. |
artikel |
60 |
Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles
|
Chakraborty, Anumita |
|
|
22 |
6 |
p. |
artikel |
61 |
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)
|
Chakrani, Zakaria |
|
|
22 |
6 |
p. |
artikel |
62 |
The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
|
Tsuboi, Ichiro |
|
|
22 |
6 |
p. |
artikel |
63 |
The Impact of Radical Prostatectomy Versus Radiation Therapy on Cancer-Specific Mortality for Nonmetastatic Prostate Cancer: Analysis of an Other-Cause Mortality Matched Cohort
|
Finati, Marco |
|
|
22 |
6 |
p. |
artikel |
64 |
Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale
|
Sternberg, Cora N. |
|
|
22 |
6 |
p. |
artikel |
65 |
Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer
|
Narayan, Vivek |
|
|
22 |
6 |
p. |
artikel |
66 |
Urachal Carcinoma: Insights From a National Database
|
Orsini, Angelo |
|
|
22 |
6 |
p. |
artikel |